Jeffrey Hung

Stock Analyst at Morgan Stanley

(3.13)
# 1,228
Out of 4,755 analysts
192
Total ratings
43.4%
Success rate
1.84%
Average return

Stocks Rated by Jeffrey Hung

Neurocrine Biosciences
Feb 4, 2025
Maintains: Overweight
Price Target: $170$185
Current: $116.85
Upside: +58.32%
PTC Therapeutics
Dec 13, 2024
Upgrades: Overweight
Price Target: $45$67
Current: $48.64
Upside: +37.76%
Amicus Therapeutics
Dec 13, 2024
Downgrades: Equal-Weight
Price Target: $17$12
Current: $9.57
Upside: +25.39%
BioAge Labs
Oct 21, 2024
Initiates: Overweight
Price Target: $40
Current: $4.34
Upside: +821.66%
Intra-Cellular Therapies
Oct 11, 2024
Maintains: Overweight
Price Target: $92$95
Current: $127.56
Upside: -25.53%
Centessa Pharmaceuticals
Sep 19, 2024
Upgrades: Overweight
Price Target: $11$26
Current: $17.26
Upside: +50.64%
enGene Holdings
Sep 11, 2024
Maintains: Overweight
Price Target: $40
Current: $6.32
Upside: +532.91%
ACADIA Pharmaceuticals
Aug 7, 2024
Downgrades: Equal-Weight
Price Target: $28$20
Current: $18.49
Upside: +8.17%
CervoMed
Jul 26, 2024
Initiates: Overweight
Price Target: $35
Current: $2.13
Upside: +1,543.19%
Jazz Pharmaceuticals
Jul 12, 2024
Maintains: Equal-Weight
Price Target: $160$150
Current: $129.98
Upside: +15.40%
Maintains: Overweight
Price Target: $50$70
Current: $34.93
Upside: +100.40%
Initiates: Overweight
Price Target: $25
Current: $7.88
Upside: +217.26%
Maintains: Equal-Weight
Price Target: $75$40
Current: $54.07
Upside: -26.02%
Initiates: Overweight
Price Target: $55
Current: $27.52
Upside: +99.85%
Downgrades: Equal-Weight
Price Target: $60$90
Current: $41.56
Upside: +116.55%
Downgrades: Underweight
Price Target: $10$4
Current: $0.92
Upside: +334.74%
Downgrades: Underweight
Price Target: $13$4
Current: $2.65
Upside: +50.94%
Upgrades: Overweight
Price Target: $29$55
Current: $57.58
Upside: -4.48%
Upgrades: Equal-Weight
Price Target: $1$4
Current: $1.68
Upside: +138.10%
Upgrades: Equal-Weight
Price Target: $60$140
Current: $6.05
Upside: +2,214.05%
Maintains: Overweight
Price Target: $90$84
Current: $43.58
Upside: +92.75%
Maintains: Equal-Weight
Price Target: $42$40
Current: $11.64
Upside: +243.64%
Maintains: Equal-Weight
Price Target: $14
Current: $1.80
Upside: +677.78%
Reiterates: Equal-Weight
Price Target: $5
Current: $1.39
Upside: +259.71%
Maintains: Equal-Weight
Price Target: $9$3
Current: $1.79
Upside: +67.60%
Maintains: Equal-Weight
Price Target: $15$14
Current: $1.18
Upside: +1,086.44%
Maintains: Overweight
Price Target: $27$19
Current: $9.81
Upside: +93.68%
Upgrades: Overweight
Price Target: $15
Current: $1.58
Upside: +849.37%
Downgrades: Underweight
Price Target: $50$10
Current: $1.97
Upside: +407.61%
Maintains: Equal-Weight
Price Target: $23$22
Current: $32.81
Upside: -32.95%
Maintains: Equal-Weight
Price Target: $146$149
Current: $42.53
Upside: +249.17%
Downgrades: Underweight
Price Target: $100$60
Current: $3.31
Upside: +1,712.69%
Maintains: Equal-Weight
Price Target: $7$6
Current: $4.21
Upside: +42.69%
Maintains: Overweight
Price Target: $58$54
Current: $0.75
Upside: +7,071.31%